The Strategist

Bayer's profit grows twofold in 2019

02/27/2020 - 09:08

Net profit of the German chemical-pharmaceutical concern Bayer AG over the past year jumped 2.4 times compared to 2018, and reached €4.091 billion, the company said.

Conan via flickr
Conan via flickr
Earnings per share were €4.17 compared to €1.8 a year earlier. Sales rose 18.5% to €43.545 billion.

In particular, the revenue of Bayer pharmaceutical division in 2019 increased by 7.3% to €17.962 billion, revenue of the Consumer Health division (OTC drugs) - by 0.2%, to €5.462 billion, and revenue of the agricultural division - by 39%, to €19.832 billion.

According to the results of the fourth quarter, the company received a net profit of €1.414 billion against a loss of €3.924 billion received a year ago. Earnings per share amounted to €1.44 compared with a loss of €4 per share in the fourth quarter of 2018. Quarterly sales increased 3.8% year-on-year, to €10.75 billion.

The company connects the dynamics of annual indicators with the sale of its veterinary unit (Animal Health) to the American company Elanco Animal Health for $ 7.6 billion, as well as its stake in Currenta and the exit from Coppertone and Dr. Scholl`s.

Bayer AG, founded in 1863, represents more than 300 companies in different countries; the product range includes about 5 thousand items in the field of healthcare, plant protection products and high-tech materials. Among the most famous Bayer brands are Aspirin, Aspirin, Alka-Seltzer, and Supradyn. At the end of 2019, the company employed 103.800 people.